Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is Swartz Schedule 13G Due According To Rule 13d-1(c) NLT Feb 14?

Your opinion please.. If Swartzy is now below 5% (we can all dream, right?) will there then be a need for him to file 13-G.. or will there just be no filing... and if that is the case (no filing) can we then assume Swartzy to be under that 5%?

Obviously anyone with an opinion please chime in....

thanks

Share
New Message
Please login to post a reply